Evidence map›Paper›PMID 35875547›Full record

ArticleFrontiers in microbiology2022

Resurgence of Respiratory Syncytial Virus Infection During COVID-19 Pandemic Among Children in Shanghai, China.

Ran Jia, Lijuan Lu, Liyun Su, Ziyan Lin, Da Gao, Haiyan Lv, Menghua Xu, Pengcheng Liu, Lingfeng Cao, Jin Xu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed, 1 pooled it
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 1 synthesis or guideline pooled it, 79 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Macrolide Resistance ofInfection and drug resistance · 2026
    Article
  8. Article
  9. Article
  10. Impact of the COVID-19 pandemic on the respiratory syncytial virus infections in children admitted with community acquired pneumonia: a retrospective study at a tertiary hospital of Northeast China.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ran JiaDepartment of Clinical Laboratory, Children's Hospital of Fudan University, Shanghai, China.
Lijuan LuDepartment of Clinical Laboratory, Children's Hospital of Fudan University, Shanghai, China.
Liyun SuDepartment of Clinical Laboratory, Children's Hospital of Fudan University, Shanghai, China.
Ziyan LinSchool of Laboratory Medicine and Life Sciences, Wenzhou Medical University, Wenzhou, China.
Da GaoSchool of Laboratory Medicine, Bengbu Medical College, Bengbu, China.
Haiyan LvSchool of Laboratory Medicine, Bengbu Medical College, Bengbu, China.
Menghua XuDepartment of Clinical Laboratory, Children's Hospital of Fudan University, Shanghai, China.
Pengcheng LiuDepartment of Clinical Laboratory, Children's Hospital of Fudan University, Shanghai, China.
Lingfeng CaoDepartment of Clinical Laboratory, Children's Hospital of Fudan University, Shanghai, China.
Jin XuDepartment of Clinical Laboratory, Children's Hospital of Fudan University, Shanghai, China.
Children's Hospital of Fudan University · CNBengbu Medical College · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Respiratory syncytial virus (RSV) is the most common pathogen causing acute lower respiratory tract infection (LRTI) in children. RSV usually peaks in winter and declines by early spring in China. The outbreak of coronavirus disease 2019 (COVID-19) was reported to bring changes to the transmission pattern of respiratory pathogens including RSV. Here in this paper, we analyzed RSV-positive nasopharyngeal aspirates from inpatients in the Children's Hospital of Fudan University from October 2019 to October 2021 and compared the clinical features of the RSV-positive patients before and during COVID-19. We found an atypical upsurge of RSV infection in the late summer of 2021 after a major suppression in 2020. RSV B was the main subtype spreading among children throughout the study. Phylogenetic analysis revealed that all RSV A strains belonged to ON1 genotype and all RSV B strains were BA9 genotype. Deduced amino acid analysis displayed different substitutions in the RSV strains observed before and during COVID-19. Demographic analysis suggested that males and infants aged under 5 months were the main populations infected with RSV by gender and age, respectively. Less severe clinical outcomes were observed in patients during COVID-19 than before the pandemic, especially in RSV B-positive patients. Our findings described the epidemiological changes in RSV infection brought by COVID-19, which further underscored the importance of continuous surveillance of RSV in the shadow of COVID-19 at both local and global scales.

Indexed as

clinical featuresCOVID-19epidemiologygenotyperespiratory syncytial virus—RSV

Identifiers

PMID35875547
PMCPMC9298468
OpenAlexW4283737943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.